Should Colchicine Become Standard Therapy for CAD?

Collaborative CME and Research Network

P. Ridker

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

CRT 2025 Insights: Management of Coronary Perforations

CRT 2025 Insights

V. Prasad

Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles

The Cardiogenic Shock Working Group

N. Kapur

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

CT FFR Is Already the Gold Standard for Ischemia Evaluation. Here Is…

Controversies in Interventional Cardiovascular Therapies - CICT 2024

K. Al-Azizi

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

Congestive Heart Failure: Symptoms, Stages and Treatment: Relieve Me…

Scottsdale Interventional Forum 2024

S. Schmaltz

Emotional Toll of Complications

The Christ Hospital Heart & Vascular Institute

W. Lombardi

ESC 2024 Insights: State-of-the-Art Lecture on Calcium Modification:…

ESC 2024 Insights

A. Kini

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern

Combined ROTA and IVL for Treating a Severe Left Main Calcified Lesi…

ARCH Advanced Revascularization Symposium

L. Wei

A Simplified, Integrated, Physiology and Evidence Based Approach to …

The Texas Heart Institute

D. Brown

Co-Registration: Do We Really Need It? - 2025 Update

ARCH Advanced Revascularization Symposium

P. Thakker

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Q&A: Are We Underusing CABG?

Cedars Sinai

J. Chikwe

Percutaneous Devices for Temporary Support of Cardiac Function

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

H. Tran